The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China

por Sun, Peng, Zhang, Fei, Chen, Cui, Bi, Xiwen, Yang, Hang, An, Xin, Wang, Fenghua, Jiang, Wenqi
Publicado 2016

Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission

por Li, Qiwen, Li, Wei, Wang, Liang, Wang, Weida, Niu, Shaoqing, Bi, Xiwen, Wang, Hanyu, Zhang, Yujing
Publicado 2015

The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer

por Duan, Fangfang, Zhong, Muyi, Ye, Jinhui, Wang, Li, Jiang, Chang, Yuan, Zhongyu, Bi, Xiwen, Huang, Jiajia
Publicado 2022

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer

por Hua, Xin, Duan, Fangfang, Huang, Jiajia, Bi, Xiwen, Xia, Wen, Song, Chenge, Wang, Li, Jiang, Chang, Yuan, Zhongyu
Publicado 2021

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer

por Duan, Fangfang, Li, Jianpei, Huang, Jiajia, Hua, Xin, Song, Chenge, Wang, Li, Bi, Xiwen, Xia, Wen, Yuan, Zhongyu
Publicado 2021

The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

por Sun, Peng, Chen, Cui, Xia, Yi, Bi, Xiwen, Liu, Panpan, Zhang, Fei, Yang, Hang, An, Xin, Jiang, Wenqi, Wang, Fenghua
Publicado 2017

Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma

por Nie, Man, Sun, Peng, Chen, Cui, Bi, Xiwen, Wang, Yu, Yang, Hang, Liu, Panpan, Li, Zhiming, Xia, Yi, Jiang, Wenqi
Publicado 2017

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer

por Yuan, Jing, Duan, Fangfang, Zhai, Wenyu, Song, Chenge, Wang, Li, Xia, Wen, Hua, Xin, Yuan, Zhongyu, Bi, Xiwen, Huang, Jiajia
Publicado 2021

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus

por Duan, Fangfang, Song, Chenge, Ma, Yuyu, Jiang, Kuikui, Xu, Fei, Bi, Xiwen, Huang, Jiajia, Hong, Ruoxi, Huang, Zhangzan, Lu, Qianyi, Yuan, Zhongyu, Wang, Shusen, Xia, Wen
Publicado 2021

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study

por Ma, Yuyu, Duan, Fangfang, Zhuang, Yue, Song, Chenge, Huang, Jiajia, Xia, Wen, Hong, Ruoxi, Zheng, Qiufan, Wang, Shusen, Shi, Yanxia, Xu, Fei, Yuan, Zhongyu, Bi, Xiwen
Publicado 2022

High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study

por Su, Yanhong, Zhang, Yarui, Hua, Xin, Huang, Jiajia, Bi, Xiwen, Xia, Wen, Wang, Xinyue, Huang, Zhangzan, Song, Chenge, Zhong, Yongyi, Shi, Yanxia, Wang, Shusen, Fan, Wei, Yuan, Zhongyu
Publicado 2021

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

por Chen, Cui, Sun, Peng, Cui, Juan, Yan, Shumei, Chen, Hao, Xia, Yi, Bi, Xiwen, Liu, Panpan, Wang, Yu, Yang, Hang, Nie, Man, Zhang, Xue‐Wen, Jiang, Wenqi, Li, Zhi‐Ming
Publicado 2019

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter,...

por Duan, Fangfang, Zhong, Muyi, Ma, Yuyu, Song, Chenge, Zhang, Lehong, Lin, Ying, Wu, Zhiyong, Zhang, Yuanqi, Huang, Jiajia, Xu, Fei, Shi, Yanxia, Wang, Shusen, Yuan, Zhongyu, Xia, Wen, Bi, Xiwen
Publicado 2022

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study

por Hong, Ruoxi, Xia, Wen, Wang, Liye, Lee, Kaping, Lu, Qianyi, Jiang, Kuikui, Li, Shengfeng, Yu, Jinquan, Wei, Jin, Tang, Weijia, Zhou, Danyang, An, Xin, Huang, Jiajia, Xue, Cong, Bi, Xiwen, Shi, Yanxia, Yuan, Zhongyu, Xu, Fei, Wang, Shusen
Publicado 2021

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database

por Ni, Mengqian, Wang, Fang, Yang, Anli, Shao, Qiong, Xue, Cong, Xia, Wen, Xu, Fei, Lin, Xi, Huang, Jiajia, Bi, Xiwen, Hong, Ruoxi, Chen, Meiting, Zheng, Qiufan, Jiang, Kuikui, Xie, Xinhua, Tang, Jun, Wang, Xi, Yuan, Zhongyu, Wang, Shusen, Shi, Yanxia, An, Xin
Publicado 2023